Mounjaro 5 Mg/0.6ml Kwikpen is a once-weekly injectable medication designed to help adults with type 2 diabetes manage their blood sugar levels effectively. With its active ingredient, Tirzepatide, this innovative solution not only lowers blood sugar but may also support weight loss, although it is not FDA approved for this purpose.
Key Features
- Subcutaneous Administration: Administered once a week for convenience.
- Pre-Filled Pen: Easy-to-use design containing 4 doses.
- FDA Fast Track Designation: Recognized for its potential in weight loss trials.
Benefits
- Reduces blood sugar levels effectively.
- Demonstrated effectiveness for weight loss in clinical trials.
- Convenient weekly dosing.
- Supports insulin production and reduces liver sugar output.
Side Effects
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Stomach pain
Important Note: Not suitable for individuals with type 1 diabetes or pancreatitis, and may cause thyroid tumors.
